PremiumCompany AnnouncementsOxford BioDynamics Announces Change in Major Holdings Oxford BioDynamics Expands Partnership with Bupa UK for Prostate Cancer Test Coverage Oxford BioDynamics Releases 2024 Annual Report Ahead of AGM PremiumCompany AnnouncementsVulpes Investment Increases Stake in Oxford BioDynamics, Signaling Market Confidence Oxford BioDynamics Expands EpiSwitch Test Availability in Romania through Regina Maria Partnership Oxford BioDynamics Announces Significant Shareholding Change PremiumCompany AnnouncementsUnicorn Asset Management Reduces Stake in Oxford BioDynamics Oxford BioDynamics’ EpiSwitch® Test Shows High Accuracy in Detecting Colorectal Cancer Cantor Fitzgerald Europe Increases Stake in Oxford BioDynamics